ATE251447T1 - Pharmazeutische zubereitungen zur inhalation eines opioids - Google Patents

Pharmazeutische zubereitungen zur inhalation eines opioids

Info

Publication number
ATE251447T1
ATE251447T1 AT98962686T AT98962686T ATE251447T1 AT E251447 T1 ATE251447 T1 AT E251447T1 AT 98962686 T AT98962686 T AT 98962686T AT 98962686 T AT98962686 T AT 98962686T AT E251447 T1 ATE251447 T1 AT E251447T1
Authority
AT
Austria
Prior art keywords
opioids
dry powder
inhalation
administered
opioid
Prior art date
Application number
AT98962686T
Other languages
English (en)
Inventor
Volcmar Verkerk
Marianne Elisabeth Blom-Ross
Dort Karin Van
Vos Dick De
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Application granted granted Critical
Publication of ATE251447T1 publication Critical patent/ATE251447T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98962686T 1998-12-11 1998-12-11 Pharmazeutische zubereitungen zur inhalation eines opioids ATE251447T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL1998/000713 WO2000035417A1 (en) 1998-12-11 1998-12-11 Pharmaceutical preparation for inhalation of an opioid

Publications (1)

Publication Number Publication Date
ATE251447T1 true ATE251447T1 (de) 2003-10-15

Family

ID=19866466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962686T ATE251447T1 (de) 1998-12-11 1998-12-11 Pharmazeutische zubereitungen zur inhalation eines opioids

Country Status (11)

Country Link
US (1) US20010041164A1 (de)
EP (1) EP1137398B1 (de)
JP (1) JP2002532405A (de)
AT (1) ATE251447T1 (de)
AU (1) AU1786199A (de)
CA (1) CA2354576C (de)
DE (1) DE69818872T2 (de)
DK (1) DK1137398T3 (de)
ES (1) ES2207867T3 (de)
IL (2) IL143576A0 (de)
WO (1) WO2000035417A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231611D1 (de) * 2001-05-24 2009-04-30 Alexza Pharmaceuticals Inc Verabreichung von opioiden durch inhalation
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
GB0219513D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
ATE520405T1 (de) * 2002-08-21 2011-09-15 Norton Healthcare Ltd Inhalationszusammensetzung
WO2004075879A1 (en) * 2003-02-28 2004-09-10 Delex Therapeutics Inc. Opioid delivery system
US20040234699A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (de) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosolverabreichungsvorrichtung mit Schlag gezündete Heizeinheit
WO2006124556A2 (en) * 2005-05-13 2006-11-23 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
EP2121088B1 (de) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Erhitzungseinheit zur verwendung in einer arzneimittelabgabevorrichtung
EP2389159A1 (de) * 2009-01-22 2011-11-30 Noramco, Inc. Verfahren zur herstellung von opioid-partikeln und so hergestellte zusammensetzungen
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation

Also Published As

Publication number Publication date
WO2000035417A1 (en) 2000-06-22
IL143576A0 (en) 2002-04-21
IL143576A (en) 2006-10-31
CA2354576A1 (en) 2000-06-22
US20010041164A1 (en) 2001-11-15
JP2002532405A (ja) 2002-10-02
CA2354576C (en) 2008-10-14
EP1137398B1 (de) 2003-10-08
ES2207867T3 (es) 2004-06-01
DE69818872T2 (de) 2004-05-19
EP1137398A1 (de) 2001-10-04
DK1137398T3 (da) 2004-02-02
AU1786199A (en) 2000-07-03
DE69818872D1 (de) 2003-11-13

Similar Documents

Publication Publication Date Title
DE69818872D1 (de) Pharmazeutische zubereitungen zur inhalation eines opioids
CA2146954A1 (en) Breath activated nicotine inhalers
Anderson History of aerosol therapy: liquid nebulization to MDIs to DPIs
EE03221B1 (et) Inhaleeritavad ravimpreparaadid, nende valmistamise protsess ja inhalaator nende kasutamiseks
US20190046436A1 (en) Nicotine formulation and aerosols
DK1019021T3 (da) Stabiliserede præparater til anvendelse i inhalatorer med afmålt dosis
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
DE69921785D1 (de) Nikotininhalator
TR200002692T2 (tr) Aerosol haline getirilen aktif maddenin verilmesi.
TNSN04149A1 (en) Pressurised metered dose inhalers containing solutions of beta-2 agonists
SE9700423D0 (sv) Disposable inhaler
Newman et al. The nasal distribution of metered does inhalers
JP2001527442A (ja) ハロセラピーの投与方法
BR0011343A (pt) Dispositivo de distribuição de medicamento,e,métodos de administrar um medicamento por inalação,e de,tratamento de um paciente com distúrbio respiratório
TW200607538A (en) Medicament inhaler device
US11006661B2 (en) Cigarette-like device for administration of substances
FI962665A0 (fi) Menetelmä ja sovitelma intuboidun potilaan hengityMenetelmä ja sovitelma intuboidun potilaan hengityskaasun käsittelemiseksi skaasun käsittelemiseksi
WO2004082633A3 (en) A method of treating a systemic disease
NO20021681L (no) Anordning for avlevering av medikament, med fuktighetsbestandig belegg
Hofmann et al. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis
ATE271852T1 (de) Verbesserte inhalationspräparate
RU2012363C1 (ru) Устройство в.а.старцева для насыщения воздуха лекарственными веществами
KIM et al. The effect of patient education on correct use of metered dose inhalers in patients with asthma
EP1110547A3 (de) Helium und Neon als Hilfsstoffe zur Wirkstoffverabreichung mittels Inhalator
CN101146563B (zh) 气雾剂形式的药品的给药设备

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137398

Country of ref document: EP

REN Ceased due to non-payment of the annual fee